Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Net Income (2022 - 2025)

Historic Net Income for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$6.2 million.

  • Envoy Medical's Net Income fell 1800.99% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.4 million, marking a year-over-year decrease of 249.28%. This contributed to the annual value of -$20.1 million for FY2024, which is 933.06% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Net Income is -$6.2 million, which was down 1800.99% from -$5.7 million recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's Net Income peaked at $12.5 million during Q1 2022, and registered a low of -$6.7 million during Q4 2023.
  • For the 4-year period, Envoy Medical's Net Income averaged around -$1.9 million, with its median value being -$4.9 million (2024).
  • The largest annual percentage gain for Envoy Medical's Net Income in the last 5 years was 2662.5% (2024), contrasted with its biggest fall of 78552.22% (2024).
  • Envoy Medical's Net Income (Quarter) stood at -$2.0 million in 2022, then plummeted by 234.69% to -$6.7 million in 2023, then grew by 26.63% to -$4.9 million in 2024, then dropped by 25.26% to -$6.2 million in 2025.
  • Its Net Income was -$6.2 million in Q3 2025, compared to -$5.7 million in Q2 2025 and -$5.6 million in Q1 2025.